These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 30048194)

  • 1. Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.
    Kontodimopoulos N; Stamatopoulou E; Brinia A; Talias MA; Ferreira LN
    Expert Rev Pharmacoecon Outcomes Res; 2018 Dec; 18(6):667-675. PubMed ID: 30048194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VALIDATION AND COMPARISON OF EQ-5D-3L AND SF-6D INSTRUMENTS IN A SPANISH PARKINSON´S DISEASE POPULATION SAMPLE.
    Garcia-Gordillo MÁ; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellan-Perpiñan JM; Sanchez-Martinez FI
    Nutr Hosp; 2015 Dec; 32(6):2808-21. PubMed ID: 26667738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes.
    Sullivan PW; Ghushchyan VH; Campbell JD; Globe G; Bender B; Magid DJ
    Qual Life Res; 2016 Dec; 25(12):3017-3026. PubMed ID: 27387417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
    J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric performance of the CFQ-R-8D compared to the EQ-5D-3L and SF-6D in people with cystic fibrosis.
    Mukuria C; Rowen D; Acaster S; McGarry LJ; Lou Y; Sosnay PR; Quittner AL
    J Patient Rep Outcomes; 2024 Feb; 8(1):24. PubMed ID: 38416239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach.
    Kontodimopoulos N; Stamatopoulou E; Gazi S; Moschou D; Krikelis M; Talias MA
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China.
    Zhao L; Liu X; Liu D; He Y; Liu Z; Li N
    Medicine (Baltimore); 2019 Mar; 98(11):e14719. PubMed ID: 30882636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.
    Kontodimopoulos N; Argiriou M; Theakos N; Niakas D
    Eur J Health Econ; 2011 Aug; 12(4):383-91. PubMed ID: 20473544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interchangeability of the EQ-5D and the SF-6D, and comparison of their psychometric properties in a spinal postoperative Spanish population.
    Selva-Sevilla C; Ferrara P; Gerónimo-Pardo M
    Eur J Health Econ; 2020 Jun; 21(4):649-662. PubMed ID: 32065301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D.
    Stolz M; Albus C; Beutel ME; Deter HC; Fritzsche K; Herrmann-Lingen C; Michal M; Petrowski K; Ronel J; Schultz JH; Söllner W; Weber C; de Zwaan M; Krauth C
    Eur J Health Econ; 2023 Nov; 24(8):1297-1307. PubMed ID: 36385438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status.
    McTaggart-Cowan HM; Marra CA; Yang Y; Brazier JE; Kopec JA; FitzGerald JM; Anis AH; Lynd LD
    Qual Life Res; 2008 Apr; 17(3):453-62. PubMed ID: 18274882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
    Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
    Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease.
    Kularatna S; Byrnes J; Chan YK; Ski CF; Carrington M; Thompson D; Stewart S; Scuffham PA
    Qual Life Res; 2017 Dec; 26(12):3399-3408. PubMed ID: 28766084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D.
    Shiroiwa T; Fukuda T; Ikeda S; Igarashi A; Noto S; Saito S; Shimozuma K
    Qual Life Res; 2016 Mar; 25(3):707-19. PubMed ID: 26303761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of EQ-5D and SF-6D utilities in Pompe disease.
    Kanters TA; Redekop WK; Kruijshaar ME; van der Ploeg AT; Rutten-van Mölken MP; Hakkaart L
    Qual Life Res; 2015 Apr; 24(4):837-44. PubMed ID: 25342117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.
    Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
    Patient; 2019 Aug; 12(4):383-392. PubMed ID: 30607809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the burden of disease in chronic pain with and without neuropathic characteristics: does the choice between the EQ-5D and SF-6D matter?
    Torrance N; Lawson KD; Afolabi E; Bennett MI; Serpell MG; Dunn KM; Smith BH
    Pain; 2014 Oct; 155(10):1996-2004. PubMed ID: 25020004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the performance of the SF-6D and the EQ-5D in different patient groups.
    Ferreira LN; Ferreira PL; Pereira LN
    Acta Med Port; 2014; 27(2):236-45. PubMed ID: 24813493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of four different approaches to measuring health utility in depressed patients.
    Turner N; Campbell J; Peters TJ; Wiles N; Hollinghurst S
    Health Qual Life Outcomes; 2013 May; 11():81. PubMed ID: 23659557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.